Evidence that activation of central 5-HT2B receptors causes renal sympathoexcitation in anaesthetized rats
Open Access
- 30 January 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 129 (1) , 177-183
- https://doi.org/10.1038/sj.bjp.0703011
Abstract
The effects of injections i.c.v. of alpha-methyl-5-(2-thienylmethoxy)-1H-indole-3-ethanamine (BW723C86; 0.02 - 2 micromol kg(-1)), a 5-HT(2B) receptor agonist, on renal sympathetic and phrenic nerve activity, mean arterial blood pressure and heart rate were investigated in alpha-chloralose anaesthetized rats pretreated with a peripherally acting 5-HT(2) receptor antagonist. BW723C86 i.c.v. caused a dose-related increase in renal nerve activity reaching a maximum of 67+/-6%, which at the highest dose was associated with a small and maintained fall in mean arterial blood pressure of 7+/-3 mmHg. These changes were not associated with any significant changes in heart rate or phrenic nerve activity. BW723C86-evoked increases in renal nerve activity and hypotension were attenuated by pretreatment (i.c.v.) with SB204741 (300 nmol kg(-1); a 5-HT(2B) receptor antagonist) but not by the same dose (i.c.v.) of ketanserin (a 5-HT(2A) receptor antagonist) or RS102221 (a 5-HT(2C) receptor antagonist). None of these antagonists alone had any effect on the variables being measured. It is concluded that central 5-HT(2B) receptors may play a selective role in the control of sympathetic supply to the kidney, which could be important in the central mechanisms involved in blood volume regulation. British Journal of Pharmacology (2000) 129, 177 - 183Keywords
This publication has 20 references indexed in Scilit:
- Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized ratsBritish Journal of Pharmacology, 1999
- BW 723C86, a 5-HT2B Receptor Agonist, Causes Hyperphagia and Reduced Grooming in RatsNeuropharmacology, 1997
- Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous systemNeuroscience, 1997
- Effects of the 5‐HT2B receptor agonist, BW 723C86, on three rat models of anxietyBritish Journal of Pharmacology, 1996
- The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptorsBritish Journal of Pharmacology, 1995
- N-(1-Methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: A Novel, High-Affinity 5-HT2B Receptor AntagonistJournal of Medicinal Chemistry, 1995
- Effect of Serotonin on Vasopressin Release: A Comparison to Corticosterone, Prolactin and ReninNeuroendocrinology, 1993
- Investigation of the effects of IVth ventricular administration of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), on autonomic outflow in the anaesthetized catBritish Journal of Pharmacology, 1991
- m-CPP: a tool for studying behavioural responses associated with 5-HT1c receptorsTrends in Pharmacological Sciences, 1990
- Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67European Journal of Pharmacology, 1986